TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
97,052
|
92,174
|
94,414 |
| Financial expenses |
1,465
|
13
|
270 |
| Earnings before taxes |
-3,708
|
-4,713
|
4,703 |
| EBITDA |
-4,309
|
-4,535
|
5,287 |
| Total assets |
67,429
|
49,761
|
43,787 |
| Current assets |
66,897
|
49,127
|
42,963 |
| Current liabilities |
44,996
|
25,351
|
13,763 |
| Equity capital |
19,759
|
21,288
|
25,988 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
57
|
65
|
57 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
29.3%
|
42.8%
|
59.4% |
| Turnover per employee |
1,703
|
1,418
|
1,656 |
| Profit as a percentage of turnover |
-3.8%
|
-5.1%
|
5.0% |
| Return on assets (ROA) |
-3.3%
|
-9.4%
|
11.4% |
| Current ratio |
148.7%
|
193.8%
|
312.2% |
| Return on equity (ROE) |
-18.8%
|
-22.1%
|
18.1% |
| Change turnover |
-1,661
|
597
|
-587 |
| Change turnover % |
-2%
|
1%
|
-1% |
| Chg. No. of employees |
-8
|
8
|
-5 |
| Chg. No. of employees % |
-12%
|
14%
|
-8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.